| Literature DB >> 28314175 |
Konrad Klinghammer1, Wolfgang Walther2, Jens Hoffmann3.
Abstract
Through the introduction of a steadily growing variety of preclinical test models drug development and biomarker research has advanced. Next to classical used 2D cell line cultures, tissue-slice cultures, 3D organoid cell cultures, genetically engineered mouse models, cell line derived mouse models and patient derived xenografts may be selected for a specific question. All models harbor advantages and disadvantages. This review focuses on the available preclinical test models, novel developments such as humanized mice and discusses for which question a particular model should be employed.Entities:
Keywords: CDX; GEMMs; PDX; Preclinical models; Tissue-slice cultures
Mesh:
Substances:
Year: 2017 PMID: 28314175 DOI: 10.1016/j.ctrv.2017.02.009
Source DB: PubMed Journal: Cancer Treat Rev ISSN: 0305-7372 Impact factor: 12.111